http://www.zibb.com/all/theme/cq/Neurocrine+Biosciences+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Wed, 28 Oct 2009 09:19:41 GMTWed, 28 Oct 2009 09:19:41 GMT608831http://www.zibb.com/all/theme/cq/Neurocrine+Biosciences+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.bio-medicine.org/medicine-technology-1/Neurocrine-Biosciences-Reports-Third-Quarter-2009-Results-5796-1/...SAN DIEGO Oct. 28 /- Neurocrine Biosciences I...Revenues for the third quarter of 2009 were $0.7 million compared wit...Research and development expenses decreased to $7.4 million during the...,Neurocrine,Biosciences,Reports,Third,Quarter,2009,Results,medicine,advanced medical technology,medicalhttp://www.bio-medicine.org/medicine-technology-1/Neurocrine-Biosciences-Reports-Third-Quarter-2009-Results-5796-1/Neurocrine Biosciences IncorporatedWed, 28 Oct 2009 09:19:41 GMThttp://www.neurocrine.com/index.cfm?navid=6Neurocrine Biosciences, Inc of San Diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs.http://www.neurocrine.com/index.cfm?navid=6Neurocrine Biosciences Incorporatedhttp://www.quotelinks.com/companies/nbix.htmlStock earnings, recommendations and SEC filings for Neurocrine Biosciences, Inc.http://www.quotelinks.com/companies/nbix.htmlNeurocrine Biosciences Incorporatedhttp://www.cheviotartus.co.uk/pre_employment_questionnaires/pre_employment_questionnaires_313.htmlSAN DIEGO, Dec. 7 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company has appointed Adrian Adams to its Board of Directors effective immediately. Mr. Adams is President and CEO of Kos Pharmaceuticals, Inc. (Nasdaq: KOSP).http://www.cheviotartus.co.uk/pre_employment_questionnaires/pre_employment_questionnaires_313.htmlNeurocrine Biosciences Incorporatedhttp://www.cytoritx.com/about/board_of_directors.htmlHenriksen joined Cytori Therapeutics as Director in October 2002 and was previously a Board member of its predecessor, StemSource, Inc. Mr. Henriksen has more than 30 years of experience in healthcare, pharmaceutical, biotechnology and consulting and venture capital industries.http://www.cytoritx.com/about/board_of_directors.htmlNeurocrine Biosciences Incorporatedhttp://www.researchandmarkets.co.uk/reportinfo.asp?report_id=56510Research and Markets Annual Reports Service provides you with quick access to annual accounts and other information on selected companies. The Annual Report Service is the most complete and up-to-date listing of Annual Reports, and related financial reports online today.http://www.researchandmarkets.co.uk/reportinfo.asp?report_id=56510Neurocrine Biosciences Incorporatedhttp://www.evaluatepharma.com/CoInfo/CoInfo-NBIX.htmEvaluatePharma provides historic and forecast sales from 1986 to 2010 for worldwide and US Rx (prescription drugs) and OTC drugs. EvaluatePharma analysts continuously update company models from SEC filings, annual reports, investor/analyst presentations, company press releases, FDA and USPTO.http://www.evaluatepharma.com/CoInfo/CoInfo-NBIX.htmNeurocrine Biosciences Incorporatedhttp://www.newratings.com/headlines/Neurocrine-Biosciences_US64125C1099.htmlCopyright © 2002 - 2008 newratings.com GmbH | Legal | Licensing Quote data provided by IS.eFinance Solutions (powered by IS.Teledata AG) using StandardPoor's ComStock Inc. and others. Delay times are 15 mins for European exchanges and NASDAQ, 20 mins for NYSE and AMEX.http://www.newratings.com/headlines/Neurocrine-Biosciences_US64125C1099.htmlNeurocrine Biosciences Incorporatedhttp://www.biospace.com/news_story.aspx?NewsEntityId=59758SAN DIEGO, June 12 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. announced today that results from several research studies on the impact of chronic primary and transient insomnia were presented this week at the Associated Professional Sleep Societies (APSS) Annual Meeting.http://www.biospace.com/news_story.aspx?NewsEntityId=59758Neurocrine Biosciences Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=7129/PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today the issuance of U.S. Patent No. 6,903,106 (the '106 patent) covering a novel polymorphic form (different crystal structure) of its proprietary compound indiplon for the treatment of insomnia.http://www.pharmacychoice.com/News/article.cfm?Article_ID=7129Neurocrine Biosciences Incorporatedhttp://www.thelabrat.com/jobs/companies/NeurocrineBiosciences.shtmlNeurocrine Biosciences is a leading neuroscience company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders.http://www.thelabrat.com/jobs/companies/NeurocrineBiosciences.shtmlNeurocrine Biosciences Incorporatedhttp://www.researchandmarkets.com/reports/576993/premium_company_profile_neurocrine_biosciences_incIntroduction Neurocrine Biosciences, a neuroscience company, focuses on the discovery and development of therapeutics for the treatment of neurological and endocrine-related diseases and disorders.http://www.researchandmarkets.com/reports/576993/premium_company_profile_neurocrine_biosciences_incNeurocrine Biosciences Incorporatedhttp://www.thestreet.com/print/story/10383196.htmlTrue story: When I lived in San Francisco, my kids didn't get the day off from school for Columbus Day. Instead, they spent the day celebrating "Indigenous Peoples Day." As my daughter explained to me, you can't "discover" a new world when plenty of people live there already.http://www.thestreet.com/print/story/10383196.htmlNeurocrine Biosciences Incorporatedhttp://www.meds.com/archive/mol-cancer/1998/11/msg03245.htmlMedtronic and Neurocrine Biosciences to Collaborate on Therapy to Treat Malignant Brain Tumors Drug and Delivery System May Offer Solution to Deadly Cancer MINNEAPOLIS, Nov. 24 /PRNewswire/ via NewsEdge Corporation -- Medtronic, Inc. (NYSE: MDT) and Neurocrine Biosciences, Inc.http://www.meds.com/archive/mol-cancer/1998/11/msg03245.htmlNeurocrine Biosciences Incorporatedhttp://www.micromedex.com/pressroom/news_feeds/?story_ID=75570&category=18Get the news that matters to you. Create your own customized news service that delivers the latest information directly to you. Plus you can view the most current press releases from Micromedex.http://www.micromedex.com/pressroom/news_feeds/?story_ID=75570&category=18Neurocrine Biosciences Incorporatedhttp://www.bio-medicine.org/medicine-technology-1/Neurocrine-Biosciences-Presents-Elagolix-Data-4601-1/...SAN DIEGO June 16 /- Neurocrine Biosciences I... ...The first clinical abstract presentation at ENDO 09 reviews the result... ...,Neurocrine,Biosciences,Presents,Elagolix,Data,medicine,advanced medical technology,medical laboratory technology,medical device technology,latest medicalhttp://www.bio-medicine.org/medicine-technology-1/Neurocrine-Biosciences-Presents-Elagolix-Data-4601-1/Neurocrine Biosciences IncorporatedTue, 16 Jun 2009 08:40:21 GMThttp://www.neurocrine.com/index.cfm?navid=7At Neurocrine Biosciences, Inc. highly-motivated individuals are working as a team to make a significant impact upon our business while progressing in their careers. We believe we have the best environment for "sky-is-the-limit" creativity, contribution, and learning.http://www.neurocrine.com/index.cfm?navid=7Neurocrine Biosciences Incorporatedhttp://www.neurocrine.com/index.cfm?navid=35A more complete description of these risks can be found in the Company’s annual report on Form 10K and most recent quarterly reports on Form 10Q.http://www.neurocrine.com/index.cfm?navid=35Neurocrine Biosciences Incorporatedhttp://www.neurocrine.com/index.cfm?navid=4Working as a team, Neurocrine’s R & D and clinical development groups possess the skills and experience to identify, select and optimize new compounds, to screen for therapeutic development, and to advance these compounds efficiently through clinical trials.http://www.neurocrine.com/index.cfm?navid=4Neurocrine Biosciences Incorporatedhttp://www.neurocrine.com/index.cfm?navid=32Copyright © 2007 Neurocrine Biosciences, Inc. San Diego, CA, USA. All rights reserved.http://www.neurocrine.com/index.cfm?navid=32Neurocrine Biosciences Incorporatedhttp://www.neurocrine.com/index.cfm?navId=49The Board of Directors of Neurocrine Biosciences, Inc. has adopted a company-wide code of ethics and has also established an ethics hotline for reporting violations of this code.http://www.neurocrine.com/index.cfm?navId=49Neurocrine Biosciences Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=26506The 3-month data comes from a multi-center, randomized, double-blind, placebo-controlled trial involving patients with a confirmed diagnosis of endometriosis.http://www.pharmacychoice.com/News/article.cfm?Article_ID=26506Neurocrine Biosciences Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=47966For Neurocrine Biosciences, it's all chemical. The development-stage biotech develops treatments for diseases of the central nervous and immune systems. It bases its research on the molecular relationships among the body's central nervous, immune, and endocrine systems.http://www.pharmacychoice.com/News/article.cfm?Article_ID=47966Neurocrine Biosciences Incorporatedhttp://www.pharmacychoice.com/News/article.cfm?Article_ID=44514The first "proof of concept" trial is a Phase II double-blind, randomized, placebo controlled, multiple dose study to evaluate the safety and efficacy of the CRF1 antagonist compound in patients with SocAD.http://www.pharmacychoice.com/News/article.cfm?Article_ID=44514Neurocrine Biosciences Incorporatedhttp://www.researchandmarkets.com/reports/576993/premium_company_profile_neurocrine.pdfNeurocrine Biosciences, a neuroscience company, focuses on the discovery and development of therapeutics for the treatment of neurological and endocrine-related diseases and disorders.http://www.researchandmarkets.com/reports/576993/premium_company_profile_neurocrine.pdfNeurocrine Biosciences Incorporated